Deadline: 26 September 2019
Health Canada announces Substance Use and Addictions Program (SUAP) to provide approximately $50 million annually in grants and contributions funding annually to other levels of government, community-led and not-for-profit organizations to respond to drug and substance use issues in Canada.
The SUAP provides funding for a wide range of evidence-informed and innovative problematic substance use prevention, harm reduction and treatment initiatives across Canada at the community, regional and national levels. Initiatives target a range of psychoactive substances, including opioids, stimulants, cannabis, alcohol, nicotine and tobacco.
At this time, the SUAP is launching an additional, one-time anticipatory call for proposals. Funding will be available, to enhance the response to the opioid crisis and other emerging issues, such as methamphetamines. Under this call for proposals, funding will be provided to projects in three streams: (1) harm reduction, community-led and front-line initiatives; (2) increasing access to pharmaceutical-grade medications; and (3) new approaches to address problematic methamphetamine use.
Priorities Area
Submissions must target one or more of the following priority areas:
- Stream 1 – Harm reduction, Community-led and Front-line Initiatives
- Stream 2 – Increasing Access to Pharmaceutical-Grade Medications
- Stream 3 – New Approaches to Address Problematic Methamphetamine Use
Program Principles
The following underlying principles must inform the content of all applications for SUAP funding, regardless of priority stream selected:
- Evidence-informed: The rationale for the proposed intervention and the specific communities or populations targeted is supported by evidence or, for more innovative initiatives, based on a clearly articulated and plausible theory of change.
- Involve those with lived and living experience of past or current substance use: Initiatives include people with lived and living experience of past or current substance use in the development and implementation of funded projects and reflect the diversity of who is affected by problematic substance use.
- Non-stigmatizing: Stigma leads to discrimination, which prevents people from accessing the services and supports they need. Initiatives model a person-centred approach, promote stigma-free language and messaging and actively support the reduction of fear, stigma, misinformation and misunderstanding at the community level.
- Community-led: Initiatives must address a community-identified need and demonstrate community involvement. Community may be defined as location based (e.g., cities, towns, neighbourhoods, regions) and/or identity based (e.g., gender groups or identities, age groups).
- Collaborative and Connected: Initiatives involve organizations from multiple disciplines, sectors (e.g., health and social services), and types (e.g., non-profit, Indigenous, governmental, academia); have appropriate support and connections to provincial and territorial health systems; and, where possible, complement existing local, regional, provincial or territorial level initiatives.
- Culturally Safe: Initiatives demonstrate appropriate knowledge and understanding of health, social, and historical context of Indigenous peoples, and strategies to improve to cultural safety and promote reconciliation in the delivery of programs.
- Sex, Gender and Trauma-informed: Initiatives recognize that sex and/or gender is relevant to prevalence and patterns of substance use, types of substances used, the physical impact of particular substances used, the sub-populations affected, the social context of use, and access to and outcomes of harm reduction and treatment programming. Initiatives recognize the impact of violence and trauma on people’s lives and health, including substance use, and integrate this knowledge into all aspects of practice and programming.
- Reduce Harms: Harm reduction initiatives aim to support individuals who use substances to live safer and healthier lives and reduce the negative health, social, and economic impacts of problematic substance use (e.g., injury, disease transmission, crime, overdose, death) at the individual and community level. Harm reduction measures do not require abstinence from substance use as a primary goal. Rather, the focus is on more immediate goals such as reducing the risk of accidental overdose, death, disease transmission and other harms by providing safer forms of use.
Priority Populations and Target Audiences
- Projects can address either a priority population – people who use drugs, or a target audience – people or organizations who serve or support this population. Projects can propose to address a combination of the two groups.
- Target audiences of the SUAP can include policy makers, health and social service providers, community-led organizations, and others who provide services to people who use drugs.
Eligibility Criteria
- The following types of organizations are eligible for funding:
- Canadian not-for-profit health organizations including hospitals, regional health councils and community health organizations;
- Canadian not-for-profit organizations and registered not-for-profit charitable organizations;
- Canadian institutions including universities, boards of education and other centres of education in Canada;
- other levels of government including Indigenous, provinces, territories and municipalities, and their agencies; and
- First Nations, Métis and Inuit not-for-profit organizations.
- Individuals, for-profit groups and Federal Crown corporations are not eligible for funding under the SUAP.
How to Apply
Applicants request for a copy of the application template via email at the address given on the website.
For more information, please visit http://bit.ly/2SwwDXb